Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EXEMESTANE Cause Wrong technique in product usage process? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Wrong technique in product usage process have been filed in association with EXEMESTANE (Exemestane). This represents 0.1% of all adverse event reports for EXEMESTANE.

8
Reports of Wrong technique in product usage process with EXEMESTANE
0.1%
of all EXEMESTANE reports
1
Deaths
2
Hospitalizations

How Dangerous Is Wrong technique in product usage process From EXEMESTANE?

Of the 8 reports, 1 (12.5%) resulted in death, 2 (25.0%) required hospitalization, and 1 (12.5%) were considered life-threatening.

Is Wrong technique in product usage process Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EXEMESTANE. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does EXEMESTANE Cause?

Fatigue (1,122) Malignant neoplasm progression (1,025) Arthralgia (943) Diarrhoea (941) Nausea (913) Neoplasm progression (692) Dyspnoea (673) Malaise (620) Headache (606) Asthenia (597)

What Other Drugs Cause Wrong technique in product usage process?

EVOLOCUMAB (21,664) ALBUTEROL (17,114) ADALIMUMAB (11,766) PEGFILGRASTIM (10,217) ETANERCEPT (9,835) ERENUMAB-AOOE (9,359) SACUBITRIL\VALSARTAN (8,022) LEUPROLIDE (5,062) FENTANYL (2,812) SEMAGLUTIDE (2,538)

Which EXEMESTANE Alternatives Have Lower Wrong technique in product usage process Risk?

EXEMESTANE vs EXENATIDE EXEMESTANE vs EXFORGE EXEMESTANE vs EXJADE EXEMESTANE vs EXTAVIA EXEMESTANE vs EXTRANEAL

Related Pages

EXEMESTANE Full Profile All Wrong technique in product usage process Reports All Drugs Causing Wrong technique in product usage process EXEMESTANE Demographics